PADRÓ CAPMANY, TERESA IR
tpadro@santpau.cat
De Santisteban Vilaplana, Victoria Marta IR
Garcia Arguinzonis, Maisa Ines IR
Gomez-pardo Arellano, Montserrat IR
Vilella Figuerola, Alba IR
Badimon L, Luquero A, Crespo J, Peña E, Borrell-Pages M. PCSK9 and LRP5 in macrophage lipid internalization and inflammation. (2020) CARDIOVASC RES. 2020 Sep 29:cvaa254. DOI: 10.1093/cvr/cvaa254. Online ahead of print. PMID: 32991689. IF: 10,787
Badimon L., Suades R., Vilella-Figuerola A., Crespo J., Vilahur G., Escate R., Padro T., Chiva-Blanch G. (2020) Liquid Biopsies: Microvesicles in Cardiovascular Disease. ANTIOXID REDOX SIGN, 33 (9), 645-662. IF: 8,4010
Ben-Aicha S, Casaní L, Muñoz-García N, Joan-Babot O, Peña E, Aržanauskaitė M, Gutierrez M, Mendieta G, Padró T, Badimon L, Vilahur G. HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging-Assessed Atherosclerotic Plaque Burden: Study in a Preclinical Experimental Model. (2020) ARTERIOSCLER THROMB VASC BIOl. 2020 Oct;40(10):2481-2493. DOI: 10.1161/ATVBAHA.120.314956. Epub 2020 Aug 27. PMID: 32847390. IF: 8,311
Ben-Aicha S, Escate R, Casaní L, Padró T, Peña E, Arderiu G, Mendieta G, Badimón L, Vilahur G. High-density lipoprotein remodelled in hypercholesterolaemic blood induce epigenetically driven down-regulation of endothelial HIF-1α expression in a preclinical animal model. (2020) CARDIOVASC RES. 2020 Jun 1;116(7):1288-1299. DOI: 10.1093/cvr/cvz239. PMID: 31504272. IF: 10,787
Bugatti A, Marsico S, Mazzuca P, Schulze K, Ebensen T, Giagulli C, Peña E, Badimón L, Slevin M, Caruso A, Guzman CA, Caccuri F. Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17. (2020) INT J MOL SCI. 2020 Mar 16;21(6):2022. DOI: 10.3390/ijms21062022. PMID: 32188077. IF: 5,923
Duncker DJ, Padro T, Dorobantu M, Tousoulis D, de Wit C. The ESC Working Group on Coronary Pathophysiology and Microcirculation. (2020) EUR HEART J. 2020 Jun 14;41(23):2150-2151. DOI: 10.1093/eurheartj/ehaa386. PMID: 32556333. IF: 29,983
Escate R, Padró T, Suades R, Camino S, Muñiz O, Diaz-Diaz JL, Sionis A, Mata P, Badimon L. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients. (2020) CARDIOVASC RES. 2021 Jan 1;117(1):109-122. DOI: 10.1093/cvr/cvaa039.(Published on line 2020). PMID: 32061123. IF: 10,787
Padro T., Manfrini O., Bugiardini R., Canty J., Cenko E., De Luca G., Duncker D.J., Eringa E.C., Koller A., Tousoulis D., Trifunovic D., Vavlukis M., De Wit C., Badimon L. (2020) ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'. CARDIOVASC RES, 116 (4), 741-755. IF: 10,7870
Padro T, Muñoz-Garcia N, Peña E, Badimon L. Sex differences and emerging new risk factors for atherosclerosis and its thrombotic complications. (2020) CURR PHARM DES. 2020 Nov 17. DOI: 10.2174/1381612826666201118094209. Online ahead of print. PMID: 33213315. IF: 3,116
Perez de Isla L., Arroyo-Olivares R., Alonso R., Muniz-Grijalvo O., Diaz-Diaz J.L., Zambon D., Fuentes F., Mata N., Piedecausa M., Manas M.D., Sanchez Munoz-Torrero J.F., Miramontes-Gonzalez J.P., De Andres R., Mauri M., Aguado R., Brea A., Cepeda J.M., Vidal-Pardo J.I., Martinez-Faedo C., Barba M.A., Argueso R., Ruiz-Perez E., Michan A., Arrieta F., Riestra Fernandez M., Perez L., Pinilla J.M., Diaz-Soto G., Pinto X., Padro T., Badimon L., Mata P., Perez-Corral B., Almagro F., Arroyo R., Isla L.P.D., Saltijeral A., Mosquera D., Casanas M., Carbayo J., Cepeda J.M., Diaz J.L., Dieguez M., Riestra M., Lopez-Miranda J., Galiana J., Garcia-Cruces J., Garrido J.A., Irigoyen L., Martinez P.L., Suarez L., Borrallo R.M., Mediavilla J.D., Jaen F., Gonzalez P., Rubio P., Miramontes P., Morera J.L., Muniz O., Gonzalez A., Pereyra F., Pastor J., Pinilla J.M., Romero M.J., Ruiz E., Alvarez M.P., Saenz P., Sanchez J.F., Sanz C., Vidal J.I. (2020) Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART. REV ESP CARDIOL, 73 (10), 828-834. IF: 4,7530
Rothenbacher D., Rehm M., Iacoviello L., Costanzo S., Tunstall-Pedoe H., Belch J.J.F., Soderberg S., Hultdin J., Salomaa V., Jousilahti P., Linneberg A., Sans S., Padro T., Thorand B., Meisinger C., Kee F., McKnight A.J., Palosaari T., Kuulasmaa K., Waldeyer C., Zeller T., Blankenberg S., Koenig W. (2020) Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project. BMC MED, 18 (1), -. IF: 8,7750
Vaccarino V., Badimon L., Bremner J.D., Cenko E., Cubedo J., Dorobantu M., Duncker D.J., Koller A., Manfrini O., Milicic D., Padro T., Pries A.R., Quyyumi A.A., Tousoulis D., Trifunovic D., Vasiljevic Z., de Wit C., Bugiardini R. (2020) Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. EUR HEART J, 41 (17), 1687-1696. IF: 29,9830